Business · Companies · 4 hrs ago

AB Science to discuss governance, inspection and growth plans at October 14 webcast

AB Science to discuss governance, inspection and growth plans at October 14 webcast

AB Science, a pharmaceutical company based in Paris, will hold a webcast on October 14, 2026.

The company says it will discuss its new governance structure, introduced three months earlier, and review a sponsor inspection conducted in September 2026.

It will also present its outlook, ambitions and short- and medium-term growth drivers.

AB Science develops medicines, including masitinib, which is approved for veterinary use and is being developed for human diseases.

The webcast is scheduled to run from 6:00 p.m.

to 7:30 p.m.

in Europe and will include a question-and-answer session.

It will be conducted in French, with presentation materials in English and French available on the company’s website when it begins.

Sources

Related news